Healthcare Contract Manufacturing Market To Reach $566.16 Billion By 2033

Healthcare Contract Manufacturing Market Growth & Trends

The global healthcare contract manufacturing market size is estimated to reach USD 566.16 billion by 2033, expanding at a CAGR of 11.7% from 2025 to 2033, according to a new report by Grand View Research, Inc. The changing regulatory landscape coupled with rising offshoring to emerging countries is anticipated to propel the healthcare contract manufacturing market growth over the forecast period. For instance, in June 2023, FUJIFILM Diosynth Biotechnologies announced to have a commercial office in Tokyo, offering contract development and manufacturing services for advanced therapies and biologics to Asian pharmaceutical and biotechnology companies.     

Due to the emergence of infections, such as COVD-19 many organizations are attempting to accelerate production to meet the growing demand. Thus, these companies are appointing healthcare CMOs to speed up their production processes, as well as reduce their overall costs to meet the increasing demand for medical products. The worldwide effort to develop a vaccine and therapeutic agent against COVID-19 has created the greatest opportunity for many large as well as small CMOs as the pharmaceutical companies are manufacturing vaccine doses on large scale. Hence, the pandemic had a positive impact on this industry.

Increasing demand for advanced products is another factor driving the industry scale. Original Equipment Manufacturers (OEMs) are outsourcing the manufacturing activities of medical devices to third parties, mainly in developing countries to gain economic benefits. Furthermore, these regions are witnessing rising cases of chronic conditions such as heart disorders, thereby positively affecting the market growth. Changes in reimbursement schemes are some of the major factors anticipated to increase the adoption of cost containment measures by OEMs. For instance, to prevent reimbursement issues from impacting financing goals, device manufacturers are developing a well-planned reimbursement strategy in parallel with their regulatory and clinical strategies in the early phases of product development.

 Request a free sample copy or view report summary: Healthcare Contract Manufacturing Market Report

Healthcare Contract Manufacturing Market Report Highlights

• The pharmaceutical segment dominated the market with a share of 78.32% in 2024 owing to a low manufacturing budget and highly sophisticated contract manufacturing service offerings

• The medical devices segment is the fastest growing segment over the forecast period owing to increasing pressure on OEMs to reduce costs and enhance the timeline for taking a product to market

• Asia Pacific held the largest revenue share of 38.68% in 2024 and is amongst the fastest growing segment over the forecast period, owing to the presence of a large number of service providers, lower costs, and growing demand for medical devices in the region

• Based on end use segment, the pharmaceutical & biotechnology companies segment accounted for the largest share in 2024 owing to their reliance on outsourcing to enhance efficiency, reduce costs, and focus on core R&D.

Healthcare Contract Manufacturing Market Segmentation

Grand View Research has segmented the global healthcare contract manufacturing market based on type, end use, and region:

Healthcare Contract Manufacturing Type Outlook (Revenue, USD Million, 2021 - 2033)

• Medical Devices

  • Service

    • Accessories manufacturing

    • Assembly manufacturing

    • Component manufacturing

    • Device manufacturing

  • Therapeutic Area

    • Oncology

    • Infectious Diseases

    • Neurological Disorders

    • Cardiovascular Disease

    • Metabolic Disorders

    • Autoimmune Diseases

    • Respiratory Diseases

    • Ophthalmology

    • Gastrointestinal Disorders

    • Hormonal Disorders

    • Hematological Disorders

    • Others

• Pharmaceutical

  • API/Bulk Drugs

  • Advanced drug delivery formulations

  • Packaging

  • Finished dose formulations

    • Solid

    • Liquid

    • Semi-solid formulations

Healthcare Contract Manufacturing End Use Outlook (Revenue, USD Million, 2021 - 2033)

• Medical Device Companies

• Pharmaceutical & Biopharmaceutical Companies

• Others

Healthcare Contract Manufacturing Regional Outlook (Revenue, USD Million, 2021 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • Thailand

  • South Korea

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • UAE

  • Saudi Arabia

  • Kuwait

  • Qatar

  • Oman

List of Key Players in the Healthcare Contract Manufacturing Market

• Nordson Corporation

• Integer Holdings Corporation

• Jabil Inc.

• Viant Technology LLC

• FLEX LTD.

• Celestica Inc.

• Sanmina Corporation

• Plexus Corp.

• Phillips-Medisize

• West Pharmaceutical Services, Inc.

• Synecco Ltd

• Catalent, Inc.

• Thermo Fisher Scientific Inc.

• Recipharm AB

• Boehringer Ingelheim International GmbH

• Lonza

• Samsung Biologics

• WuXi AppTec

• FUJIFILM Diosynth Biotechnologies

• Cambrex Corporation